Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-07-25 Purchase | 2023-07-27 4:23 pm | Turnstone Biologics Corp. | TSBX | Versant Ventures V LLC Versant Venture Capital V L.P. Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Ventures V GP-GP (Canada) Inc. Versant Ventures V (Canada) L.P. Versant Venture Capital V (Canada) LP Versant Vantage II GP-GP LLC Versant Vantage II GP L.P. Versant Vantage II L.P. 10% Owner | 225,000 | $12 | $2,700,000 | 82,006 (Indirect) | View |
| 2023-07-25 Purchase | 2023-07-27 4:21 pm | Turnstone Biologics Corp. | TSBX | Jerel Davis Director 10% Owner | 225,000 | $12 | $2,700,000 | 82,006 (Indirect) | View |
| 2023-07-20 Purchase | 2023-07-24 4:40 pm | Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner | 416,666 | $12 | $4,999,992 | 3,099,265 (Indirect) | View |
| 2023-07-20 Purchase | 2023-07-24 4:38 pm | Turnstone Biologics Corp. | TSBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 416,666 | $12 | $4,999,992 | 3,099,265 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-15 Option Award | 2024-04-16 5:38 pm | N/A 2034-04-14 | Turnstone Biologics Corp. | TSBX | Waddill William D. Director | 25,540 | $0 | 25,540 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 6:42 pm | N/A 2033-10-15 | Turnstone Biologics Corp. | TSBX | Ramanan Venkat Chief Financial Officer | 46,606 | $0 | 46,606 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 6:41 pm | N/A 2033-10-15 | Turnstone Biologics Corp. | TSBX | Rajangam Kanya Director | 8,012 | $0 | 8,012 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 6:40 pm | N/A 2033-10-15 | Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner | 25,540 | $0 | 25,540 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 6:39 pm | N/A 2033-10-15 | Turnstone Biologics Corp. | TSBX | Jerel Davis Director 10% Owner | 25,540 | $0 | 25,540 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 6:38 pm | N/A 2033-10-15 | Turnstone Biologics Corp. | TSBX | Campisi Peter Joseph Jr. Chief Legal Officer | 44,377 | $0 | 44,377 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 6:37 pm | N/A 2033-10-15 | Turnstone Biologics Corp. | TSBX | Burgess Michael F. Interim Chief Medical Officer | 11,464 | $0 | 11,464 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 6:36 pm | N/A 2033-10-15 | Turnstone Biologics Corp. | TSBX | Azmat Saryah Chief Business Officer | 56,637 | $0 | 56,637 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 6:35 pm | N/A 2033-10-15 | Turnstone Biologics Corp. | TSBX | ABBOT STEWART Chief Scientific Officer | 45,542 | $0 | 45,542 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-17 6:34 pm | N/A 2033-10-15 | Turnstone Biologics Corp. | TSBX | Farah Sammy J. President & CEO | 155,321 | $0 | 155,321 (Direct) | View |
| 2023-07-25 Conversion | 2023-07-27 4:23 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | Versant Ventures V LLC Versant Venture Capital V L.P. Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Ventures V GP-GP (Canada) Inc. Versant Ventures V (Canada) L.P. Versant Venture Capital V (Canada) LP Versant Vantage II GP-GP LLC Versant Vantage II GP L.P. Versant Vantage II L.P. 10% Owner | 28,369,890 | $0 | 82,006 (Indirect) | View |
| 2023-07-25 Conversion | 2023-07-27 4:21 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | Jerel Davis Director 10% Owner | 28,369,890 | $0 | 82,006 (Indirect) | View |
| 2023-07-25 Conversion | 2023-07-27 08:42 am | N/A N/A | Turnstone Biologics Corp. | TSBX | FMR LLC See Remark 1 10% Owner | 1,133,987 | $0 | 4,939 (Indirect) | View |
| 2023-07-20 Conversion | 2023-07-24 4:40 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner | 5,365,198 | $0 | 3,099,265 (Indirect) | View |
| 2023-07-20 Conversion | 2023-07-24 4:38 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 5,365,198 | $0 | 3,099,265 (Indirect) | View |
Ownership | 2023-07-20 9:53 pm | N/A 2032-06-29 | Turnstone Biologics Corp. | TSBX | Ramanan Venkat Chief Financial Officer | 0 | $0 | 175,280 (Direct) | View |
Ownership | 2023-07-20 9:52 pm | N/A 2032-01-19 | Turnstone Biologics Corp. | TSBX | Rajangam Kanya Director | 0 | $0 | 35,056 (Direct) | View |
Ownership | 2023-07-20 9:52 pm | N/A 2028-08-06 | Turnstone Biologics Corp. | TSBX | Machado Patrick Director | 0 | $0 | 61,719 (Direct) | View |
Ownership | 2023-07-20 9:51 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | Gupta Rishi Director 10% Owner | 0 | $0 | 2,682,599 (Indirect) | View |
Ownership | 2023-07-20 9:50 pm | N/A 2029-06-09 | Turnstone Biologics Corp. | TSBX | Gould Robert J Director | 0 | $0 | 52,902 (Direct) | View |
Ownership | 2023-07-20 9:50 pm | N/A 2025-12-31 | Turnstone Biologics Corp. | TSBX | Farah Sammy J. President & CEO | 0 | $0 | 775,914 (Direct) | View |
Ownership | 2023-07-20 9:49 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | Jerel Davis Director 10% Owner | 0 | $0 | 3,156,692 (Indirect) | View |
Ownership | 2023-07-20 9:49 pm | N/A 2033-05-30 | Turnstone Biologics Corp. | TSBX | Chiruvolu Vijay Int. Chief Technology Officer | 0 | $0 | 176,344 (Direct) | View |
Ownership | 2023-07-20 9:48 pm | N/A 2031-09-09 | Turnstone Biologics Corp. | TSBX | Campisi Peter Joseph Jr. Chief Legal Officer | 0 | $0 | 114,624 (Direct) | View |
Ownership | 2023-07-20 9:48 pm | N/A 2027-09-14 | Turnstone Biologics Corp. | TSBX | Burgess Michael F. Interim Chief Medical Officer | 0 | $0 | 210,422 (Direct) | View |
Ownership | 2023-07-20 9:47 pm | N/A 2029-10-31 | Turnstone Biologics Corp. | TSBX | Azmat Saryah Chief Business Officer | 0 | $0 | 176,344 (Direct) | View |
Ownership | 2023-07-20 9:46 pm | N/A 2031-06-15 | Turnstone Biologics Corp. | TSBX | ABBOT STEWART Chief Scientific Officer | 0 | $0 | 176,343 (Direct) | View |
Ownership | 2023-07-20 9:46 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | Versant Ventures V LLC Versant Venture Capital V L.P. Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Ventures V GP-GP (Canada) Inc. Versant Ventures V (Canada) L.P. Versant Venture Capital V (Canada) LP Versant Vantage II GP-GP LLC Versant Vantage II GP L.P. Versant Vantage II L.P. 10% Owner | 0 | $0 | 3,156,692 (Indirect) | View |
Ownership | 2023-07-20 9:45 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 0 | $0 | 2,682,599 (Indirect) | View |
Ownership | 2023-07-20 9:03 pm | N/A N/A | Turnstone Biologics Corp. | TSBX | FMR LLC See Remark 1 10% Owner | 0 | $0 | 1,133,987 (Indirect) | View |